IMP-RT3 is a long-acting lipid-modified synthetic peptide engineered for advanced laboratory investigation of integrated metabolic signaling systems. The molecule consists of a 39-amino-acid backbone with structural modifications designed to enhance stability and prolong receptor interaction kinetics under controlled in-vitro conditions. This compound belongs to a class of tri-agonist peptide architectures, meaning its design enables coordinated interaction with multiple complementary receptor systems involved in metabolic and nutrient-signaling pathways. In controlled research environments, peptides of this structure are used to explore complex endocrine signaling networks, multi-axis receptor dynamics, and integrated hormonal feedback mechanisms. The lipid-modified design contributes to extended stability and sustained signaling behavior, making IMP-RT3 a useful platform for investigating long-acting peptide signaling models within metabolic regulatory systems.